Emergent Biosolutions EBS Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's accrued manufacturing costs?
- Emergent Biosolutions (EBS) reported accrued manufacturing costs of $22M in Q1 2026.
- How has Emergent Biosolutions's accrued manufacturing costs changed year-over-year?
- Emergent Biosolutions's accrued manufacturing costs decreased by 10.9% year-over-year, from $24.7M to $22M.
- What is the long-term trend for Emergent Biosolutions's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Emergent Biosolutions's accrued manufacturing costs has grown at a -13.2% compound annual growth rate (CAGR), from $84.6M to $41.8M.